IMCR

Conviction 51HealthcareScan · Mon, Aug 10, 2026

IMCR$33.96-0.12%

ResistanceSupportVol 14

Vol MA14 484.74K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Immunocore Holdings plcBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.immunocore.com ↗

Price33.96

Change-0.12%

Gap+0.21%

Rel volume0.84×

Avg volume528.26K

Avg $ vol18.03M

SMA 2034.10

SMA 5031.68

SMA 20032.51

Price vs 50+7.20%

Price vs 200+4.45%

MA stackmixed

50/200 cross—

Supertrendup · 30.90

RSI (14)55

MACD hist-0.17

MACD cross—

Stoch %K / %D46 / 50

ADX (14)18

+DI / −DI18 / 14

RSI divergence—

MACD divergence—

ATR %+4.16%

ADR %4.20%

52w high40.22

52w low27.79

From 52w high-15.55%

Above 52w low+22.20%

New 52w highNo

SqueezeOn · 1d

Bollinger width9.11%

%B0.46

Donchian pos46.94%

Donchian high36.26

Donchian low31.93

AVWAP (52w high)31.93

vs AVWAP high+6.36%

AVWAP (52w low)31.21

vs AVWAP low+8.82%

OBV trendFlat

Chaikin MF (20)0.18

Today vs 20d0.84×

Avg vol (14d)484.74K

Avg vol (20d)528.26K

Avg $ vol (20d)18.03M

Market cap1.75B

RS 3m (vs SPY)+5.34%

RS 6m (vs SPY)-4.15%

RS line new highNo

Trend template5/8

Technical rank59.4

1 week+4.72%

1 month+6.29%

3 months+14.81%

6 months+6.19%

1 year+6.36%

YTD+0.53%

P/E-49.25

P/B4.17

P/S4.37

P/FCF-116.19

EPS-0.7100

Div yield—

ROE-8.46%

ROA-3.17%

Debt/Eq1.04

Current4.47

EV/EBITDA-40.30

Gross margin—

Net margin-8.88%

Rev growth28.95%

EPS growth30.48%

Price target65.40

Target upside92.58%

Analyst ratingBuy

Institutional100.81%

Ent. value1.7B

Revenue115.93M

Net income-808K

Gross profit—

Free cash flow-15.05M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out50.87M

Employees524

ListedFri, Feb 5, 2021

Free float44.17M

Float %85.8%

Short interest8.94M

Days to cover12.6d

Short volume18.1%

Squeeze score65 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.02 vs −$0.01

Last surprise-100.0% miss

Setup gradeC

Conviction51 / 100

Pattern quality—

Tech rank59.4 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance36.01

Support28.85

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IMCR

All disclosures →

No recent disclosed trades by Congress in IMCR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMCR · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Peterson Kristine Director · Share Option (Right to Buy) · 2026-05-27	Grant	27.49K	$0	2026-05-27	2026-05-28
Herbst Roy Steven Director · Share Option (Right to Buy) · 2026-05-27	Grant	27.49K	$0	2026-05-27	2026-05-28
Ratcliffe Peter John Director · Share Option (Right to Buy) · 2026-05-27	Grant	27.49K	$0	2026-05-27	2026-05-28
Bell John Irving Director · Share Option (Right to Buy) · 2026-05-27	Grant	27.49K	$0	2026-05-27	2026-05-28
Pao William Director · Share Option (Right to Buy) · 2026-05-27	Grant	27.49K	$0	2026-05-27	2026-05-28
Kaul Siddharth Director · Share Option (Right to Buy) · 2026-05-27	Grant	27.49K	$0	2026-05-27	2026-05-28

SEC filings

EDGAR filings in IMCR · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.